Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancer.

导出 OA

翻译打印收藏纠错

作者： Valerie W,Rusch ^[1] ; Alan,Nicholas ^[2] ; G Alexander,Patterson ^[3] ; Salama N,Waqar ^[3] ; Eric M,Toloza ^[4] ; Eric B,Haura ^[4] ; Dan J,Raz ^[5] ; Karen L,Reckamp ^[5] ; Robert E,Merritt ^[6] ; Dwight H,Owen ^[6] ; David J,Finley ^[7] ; Ciaran J,McNamee ^[8] ; Justin D,Blasberg ^[9] ; Edward B,Garon ^[10] ; John D,Mitchell ^[11] ; Robert C,Doebele ^[11] ; Frank,Baciewicz ^[12] ; Misako,Nagasaka ^[13] ; Harvey I,Pass ^[14] ; Katja,Schulze ^[2] ; Ann,Johnson ^[2] ; Paul A,Bunn ^[11] ; Bruce E,Johnson ^[15] ; Mark G,Kris ^[16] ; David J,Kwiatkowski ^[8] ; Ignacio I,Wistuba ^[17] ; Jamie E,Chaft ^[16] ; David P,Carbone ^[6] ; Jay M,Lee ^[10]

作者单位： Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY. Electronic address: ruschv@mskcc.org. ^[1] Genentech, Inc, South San Francisco, Calif. ^[2] Washington University School of Medicine, St Louis, Mo. ^[3] H. Lee Moffitt Cancer Center, Tampa, Fla. ^[4] Cedars Sinai (previously City of Hope Comprehensive Cancer Center), Los Angeles, Calif. ^[5] The Ohio State Medical Center and the Pelotonia Institute for Immune Oncology, Columbus, Ohio. ^[6] Dartmouth-Hitchcock Medical Center, Lebanon, NH. ^[7] Brigham and Women's Hospital, Boston, Mass. ^[8] Yale School of Medicine, New Haven, Conn. ^[9] David Geffen School of Medicine at UCLA, Los Angeles, Calif. ^[10] University of Colorado Cancer Center, Aurora, Colo. ^[11] Wayne State University, Detroit, Mich. ^[12] Karmanos Cancer Institute, Detroit, Mich. ^[13] New York University, New York, NY. ^[14] Dana-Farber Cancer Institute, Boston, Mass. ^[15] Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY. ^[16] The University of Texas MD Anderson Cancer Center, Houston, Tex. ^[17]

关键词 immunotherapy lung cancer neoadjuvant therapy